Acs Medicinal Chemistry Letters
-
Publication Venue For
- Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity.. 11:2290-2293. 2020
- Synthesis and Evaluation of a 18F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET.. 9:606-611. 2018
- Elimination of HIV-1 Latently Infected Cells by Gnidimacrin and a Selective HDAC Inhibitor.. 9:268-273. 2018
- Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.. 8:1199-1203. 2017
- Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors.. 7:240-244. 2016
- Phenolic diterpenoid derivatives as anti-influenza a virus agents.. 6:355-358. 2015
- Identification and synthesis of quinolizidines with anti-influenza a virus activity.. 5:942-946. 2014
- Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties.. 5:905-910. 2014
- Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention.. 5:485-490. 2014
- Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor.. 4:1005-1010. 2013
- Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.. 4:846-851. 2013
- Discovery of dabrafenib: A selective inhibitor of Raf Kinases with antitumor activity against B-Raf-driven tumors. 4:358-362. 2013
- From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules.. 3:721-725. 2012
- Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators.. 3:925-930. 2012
- In Vitro and In Vivo Osteogenic Activity of Largazole.. 2:248-251. 2011